Dipropyldopamine

Dipropyldopamine (DPDA), also known as N,N-di-n-propyldopamine, is a synthetic dopamine receptor agonist related to the catecholamine neurotransmitter dopamine which has been used in scientific research.

Uses your system voice; voice and rate in settings.

Snapshot

≈ 2 min read

Names in other languages

No names in other languages are held for this entry yet.

Article bodies are English and are not machine-translated. A name in another language is not a translation of the article.

Dipropyldopamine (DPDA), also known as N,N-di-n-propyldopamine, is a synthetic dopamine receptor agonist related to the catecholamine neurotransmitter dopamine which has been used in scientific research. It is a dual agonist of both dopamine D 1 -like and D 2 -like receptors, with much greater potency at dopamine D 2 receptors than dopamine itself.

Unlike dopamine, the drug lacks β-adrenergic receptor activity and also has weaker vasoconstrictor effects. DPDA produces hypolocomotion across a wide range of doses in rodents. It modestly reduces climbing behavior at low doses and markedly enhances it at much high doses.

The drug is thought to be resistant to metabolism by monoamine oxidase (MAO) but to still be susceptible to metabolism by catechol O-methyltransferase (COMT). It was virtually inactive orally in rodents. In contrast to dopamine, which is peripherally selective, DPDA can cross the blood–brain barrier and produce effects in the central nervous system.

DPDA was first described in the scientific literature by 1977. Other N,N-dialkyl derivatives of dopamine besides DPDA have been studied. In addition, esters of DPDA have been developed and studied.

Text derived from https://en.wikipedia.org/w/index.php?oldid=1368132787 under CC BY-SA 4.0; modifications have been made.

Sources cited in this revision

3 named source(s) extracted from the cited revision. A source with no author is shown by its publication; nothing is invented.